177 related articles for article (PubMed ID: 27588469)
1. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
Jikuya R; Kishida T; Sakaguchi M; Yokose T; Yasui M; Hashizume A; Tatenuma T; Mizuno N; Muraoka K; Umemoto S; Kawai M; Yoshihara M; Nakamura Y; Miyagi Y; Sasada T
Cancer Immunol Immunother; 2020 Oct; 69(10):2041-2051. PubMed ID: 32424467
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic Tissues in Patients With Breast Cancer.
Yamanaka T; Oshima T; Murayama D; Okamoto S; Matsui AI; Yasukawa M; Matsubara Y; Toda S; Hiroshima Y; Aoyama T; Suganuma N; Rino Y; Saito A; Miyagi Y; Iwasaki H; Yamashita T
Anticancer Res; 2023 May; 43(5):2145-2154. PubMed ID: 37097684
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis.
Tian Y; Hong M; Jing S; Liu X; Wang H; Wang X; Kaushik D; Rodriguez R; Wang Z
Biomed Res Int; 2017; 2017():9591506. PubMed ID: 28154828
[No Abstract] [Full Text] [Related]
6. RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma.
Zhou D; Kannappan V; Chen X; Li J; Leng X; Zhang J; Xuan S
Exp Mol Med; 2016 Jun; 48(6):e238. PubMed ID: 27282106
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.
Gholamalizadeh H; Zafari N; Velayati M; Fiuji H; Maftooh M; Ghorbani E; Hassanian SM; Khazaei M; Ferns GA; Nazari E; Avan A
Clin Exp Med; 2023 Dec; 23(8):4369-4383. PubMed ID: 37405571
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
Wang ZY; Jiang YZ; Xiao W; Xue XB; Zhang XW; Zhang L
BMC Cancer; 2021 Sep; 21(1):988. PubMed ID: 34479538
[TBL] [Abstract][Full Text] [Related]
9. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons.
Gisina A; Kim Y; Yarygin K; Lupatov A
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139228
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of N6-methyladenosine-modified related chemotransferase METTL3 in gastric carcinoma: Evidence from meta-analysis.
Zhu C; Wu Q; Xu Y; Ma J; Hu Y; Wang J; Gao Z; Da M
Int J Biol Markers; 2023 Dec; 38(3-4):185-193. PubMed ID: 37394831
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis.
Liu S; Liu C; Min X; Ji Y; Wang N; Liu D; Cai J; Li K
PLoS One; 2013; 8(11):e81050. PubMed ID: 24282568
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of pretreatment albumin/globulin ratio in digestive system cancers: A meta-analysis.
Guo HW; Yuan TZ; Chen JX; Zheng Y
PLoS One; 2018; 13(1):e0189839. PubMed ID: 29300750
[TBL] [Abstract][Full Text] [Related]
13. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Fellhofer-Hofer J; Franz C; Vey JA; Kahlert C; Kalkum E; Mehrabi A; Halama N; Probst P; Klupp F
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791414
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes and prognosis in RCC.
Beuselinck B; Fridman WH; Zucman-Rossi J
Aging (Albany NY); 2015 Apr; 7(4):219-20. PubMed ID: 25885644
[No Abstract] [Full Text] [Related]
15. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
16. Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis.
Wang B; Pu R
World J Surg Oncol; 2023 Dec; 21(1):390. PubMed ID: 38114977
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.
Li D; Lv H; Hao X; Hu B; Song Y
Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305
[TBL] [Abstract][Full Text] [Related]
18. Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis.
Ren L; Liu J; Gou K; Xing C
J Cancer; 2018; 9(12):2082-2092. PubMed ID: 29937926
[No Abstract] [Full Text] [Related]
19. Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time.
Ali A; Adams DL; Kasabwala DM; Tang CM; Ho TH
Sci Rep; 2023 Jun; 13(1):10544. PubMed ID: 37386095
[TBL] [Abstract][Full Text] [Related]
20. Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer.
Gamallat Y; Felipe Lima J; Seyedi S; Li Q; Rokne JG; Alhajj R; Ghosh S; Bismar TA
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
